Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1

被引:24
作者
Frederiksen, C. B. [1 ]
Lomholt, A. F. [1 ]
Lottenburger, T. [2 ]
Davis, G. J. [3 ]
Dowell, B. L. [3 ]
Blankenstein, M. A. [4 ]
Christensen, I. J. [5 ]
Brunner, N. [6 ]
Nielsen, H. J. [1 ]
机构
[1] Hvidovre Univ Hosp, Dept Surg Gastroenterol, DK-2650 Hvidovre, Denmark
[2] Univ So Denmark, Rheumatism Fdn Hosp, Grasten, Denmark
[3] Abbott Labs, Abbott Pk, IL 60064 USA
[4] VU Med Ctr, Dept Clin Chem, Amsterdam, Netherlands
[5] Copenhagen Bioctr, Finsen Lab, Copenhagen, Denmark
[6] Univ Copenhagen, Inst Vet Pathobiol, Fac Life Sci, Frederiksberg, Denmark
关键词
tissue inhibitor of metalloproteinases-1; biological variability; analytical performance; circadian variation; physical exercise;
D O I
10.1177/172460080802300107
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Tissue inhibitor of metalloproteinases-1 (TIMP-1) measurements in plasma may be useful for the early detection and prognosis of colorectal cancer (CRC). Data on analytical performance and normal intra- and interindividual biological variation are required in order to interpret the utility of TIMP-1 in CRC. The aim of this study was to establish the biological and analytical variation of plasma TIMP-1 in volunteers. Material and methods: Three separate studies were undertaken. 1: Plasma was collected from 23 volunteers 6 times within a 3-week period, first in September 2004 (round [R] 1), then repeated in May 2005 (R2) and May 2006 (R3) in the same group of individuals. TIMP-1 levels were determined by the MAC15 ELISA assay and with the Abbott ARCHITECT i2000 Immunoanalyzer. 2: Circadian variation was evaluated in plasma collected 7 times within a 24-hour period (n=16). 3: Effects of physical exercise were evaluated in plasma collected before and after bicycling (n=14). in studies 2 and 3 TIMP-1 levels were determined with the MAC15 ELISA assay only. Results: A significant correlation between TIMP-1 MAC15 and ARCHITECT i2000 was shown (r(s)=0.78, p<0.002), with consistently higher levels being detected by the ARCHITECT i2000. Median levels of TIMP-1 (ARCHITECT) at 8 a.m. in each round were 74.9 ng/mL (range 65.7-89.9) (R1), 87.3 ng/mL (range 72.7-127.9) (R2), and 81.9 ng/mL (range 66.8-113.6) (R3). The within-subject variation was 10.7%, the variation between rounds was 7.4%, and the intraclass correlation was 46.2%. Comparison between the 3 rounds and time of collection showed that TIMP-1 values decreased by 11% after storage for more than 16 months (p=0.0002). A systematic circadian variation in plasma TIMP-1 levels was not observed (p=0.17). No significant variation of plasma TIMP-1 was found in relation to physical exercise (p=0.92 [global test]). Conclusion: Levels of plasma TIMP-1 in volunteers show limited circadian, day-to-day, week-to-week and season-to-season variation. In addition, physical exercise has no impact on plasma TIMP-1 levels. Possible storage-dependent decreases in plasma TIMP-1 levels warrant further investigation.
引用
收藏
页码:42 / 47
页数:6
相关论文
共 28 条
[1]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[2]   Novel functions of TIMPs in cell signaling [J].
Chirco, R ;
Liu, XW ;
Jung, KK ;
Kim, HRC .
CANCER AND METASTASIS REVIEWS, 2006, 25 (01) :99-113
[3]  
Cornelius LA, 1998, J IMMUNOL, V161, P6845
[4]  
DAVIS GJ, 2006, TUMOUR BIOL S2, V27, pS59
[5]   Inhibition of endothelial cell migration by gene transfer of tissue inhibitor of metalloproteinases-1 [J].
Fernandez, HA ;
Kallenbach, K ;
Seghezzi, G ;
Grossi, E ;
Colvin, S ;
Schneider, R ;
Mignatti, P ;
Galloway, A .
JOURNAL OF SURGICAL RESEARCH, 1999, 82 (02) :156-162
[6]   Metalloproteinases and their inhibitors:: Influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas [J].
Görögh, T ;
Beier, UH ;
Bäumken, J ;
Meyer, JE ;
Hoffmann, M ;
Gottschlich, S ;
Maune, S .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2006, 28 (01) :31-39
[7]   Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent [J].
Gouyer, V ;
Conti, M ;
Devos, P ;
Zerimech, F ;
Copin, MC ;
Créme, E ;
Wurtz, A ;
Porte, H ;
Huet, G .
CANCER, 2005, 103 (08) :1676-1684
[8]   GROWTH-PROMOTING ACTIVITY OF TISSUE INHIBITOR OF METALLOPROTEINASES-1 (TIMP-1) FOR A WIDE-RANGE OF CELLS - A POSSIBLE NEW GROWTH-FACTOR IN SERUM [J].
HAYAKAWA, T ;
YAMASHITA, K ;
TANZAWA, K ;
UCHIJIMA, E ;
IWATA, K .
FEBS LETTERS, 1992, 298 (01) :29-32
[9]   Matrix metalloproteinases in human melanoma [J].
Hofmann, UB ;
Westphal, JR ;
van Muijen, GNP ;
Ruiter, DJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) :337-344
[10]   Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival:: a validation study [J].
Holten-Andersen, M ;
Christensen, IJ ;
Nilbert, M ;
Bendahl, PO ;
Nielsen, HJ ;
Brünner, N ;
Fernebro, E .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (01) :64-72